121497-13-0 Usage
Uses
Used in Organic Synthesis:
(1R)-1-C-[3,5-bis(methoxycarbonyl)-2,6-dimethyl-1,4-dihydropyridin-4-yl]-D-arabinitol serves as a valuable building block in organic synthesis. Its distinct structure allows it to be a component in the creation of more complex organic molecules, which can have a range of applications.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (1R)-1-C-[3,5-bis(methoxycarbonyl)-2,6-dimethyl-1,4-dihydropyridin-4-yl]-D-arabinitol is utilized in research and development for potential drug candidates. Its specific properties make it a promising starting point for the design of new medicinal compounds.
Used in Material Development:
(1R)-1-C-[3,5-bis(methoxycarbonyl)-2,6-dimethyl-1,4-dihydropyridin-4-yl]-D-arabinitol may also find applications in the development of new materials and compounds for various industrial purposes. Its unique structure could contribute to the creation of innovative materials with specialized properties.
Check Digit Verification of cas no
The CAS Registry Mumber 121497-13-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,1,4,9 and 7 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 121497-13:
(8*1)+(7*2)+(6*1)+(5*4)+(4*9)+(3*7)+(2*1)+(1*3)=110
110 % 10 = 0
So 121497-13-0 is a valid CAS Registry Number.
121497-13-0Relevant articles and documents
Syntheses and bioevaluation of substituted dihydropyridines for pregnancy-interceptive activity in hamsters
Mukherjee,Akhtar,Sharma,Seth,Bhaduri,Agnihotri,Mehrotra,Kamboj
, p. 2297 - 2300 (2007/10/02)
A number of 2,6-dimethyl-3,5-bis(methoxycarbonyl)-4-substituted-1,4-dihydropyridines were synthesized and evaluated for pregnancy-interceptive activity in mated hamsters. Our of 24 compounds, 12, 15, 21, 22, 28, and 34 caused a marked reduction in the number of implantations when administered on days 3-8 postcoitum. In an in vitro competition assay, none of the compounds exhibited noticeable binding affinity for uterine progesterone receptors. The results reported here have helped to identify new leads for developing pregnancy-interceptive agents and the active compounds do not seem to elicit their interceptive effect through receptor-mediated inhibition of progesterone action in hamster uterus.